Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Neurotech Pharmaceuticals appoints Peter J. McDonnell, MD, to Board of Directors
Photo of Peter J. McDonnell, MD, provided by Neurotech and used with permission Neurotech Pharmaceuticals, Inc., has appointed had Peter J. McDonnell, MD, to the Board of Directors. McDonnell, along with being a long-time member of the Ophthalmology Times Editorial…
EMA grants Orphan designations to MCO-010, FDA grants RMAT in Stargardt disease
(Image credit: AdobeStock/Pete) The European Medicines Agency (EMA) granted Orphan designations to MCO-010 (sonpiretigene isteparvovec) across 5 categories of retinal dystrophies. The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD). The EMA…
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – The Globe and Mail
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones The Globe and Mail Source: Author: | Date: 2025-09-02 12:12:00 Source: Author: | Date: 2025-09-02 12:12:00
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com – Financial Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com Financial Times Source: Author: | Date: 2025-09-02 12:00:00 Source: Author: | Date: 2025-09-02 12:00:00
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Laotian Times
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones Laotian Times Source: Author: | Date: 2025-09-02 12:00:00 Source: Author: | Date: 2025-09-02 12:00:00
FDA Approves Revolutionary Eye Drops to Treat Near Vision Loss Without Glasses – Vocal
FDA Approves Revolutionary Eye Drops to Treat Near Vision Loss Without Glasses Vocal Source: Author: | Date: 2025-09-01 14:00:00 Source: Author: | Date: 2025-09-01 14:00:00
New insights show “later is better” for some LHON interventions
(Image Credit: AdobeStock/Brian Jackson) Neuro-ophthalmologist Alfredo Sadun, MD, PhD, has helped uncover surprising results from gene therapy research for Leber hereditary optic neuropathy (LHON), revealing effects far beyond the initially treated eye. LHON is a rare genetic disorder that causes…
TME Pharma’s Strategic Restructuring and Capital Efficiency: A Pathway to Value Realization in Oncology and Ophthalmology – AInvest
TME Pharma’s Strategic Restructuring and Capital Efficiency: A Pathway to Value Realization in Oncology and Ophthalmology AInvest Source: Author: | Date: 2025-09-01 09:30:00 Source: Author: | Date: 2025-09-01 09:30:00
Barti Software raises $12M Series A for AI-powered electronic health records for eye care
(Image Credit: AdobeStock/Aliaksandr Marko) Barti Software announced a $12 million Series A investment led by Five Elms Capital to scale its go-to-market efforts, grow its team across key functions, and accelerate development of new AI capabilities and workflow automation as Barti expands…
Renowned eye surgeon Dr Sajjad Fazili honoured with ‘excellence award’ at National Ophthalmology Conference – Rising Kashmir
Renowned eye surgeon Dr Sajjad Fazili honoured with ‘excellence award’ at National Ophthalmology Conference Rising Kashmir Source: Author: | Date: 2025-08-30 18:37:00 Source: Author: | Date: 2025-08-30 18:37:00